<https://invivoscribe.com/invivoscribe-submits-the-leukostrat-cdx-flt3-mutation-assay-to-support-daiichi-sankyo-submission-for-quizartinib-in-japan/#article>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://invivoscribe.com/invivoscribe-submits-the-leukostrat-cdx-flt3-mutation-assay-to-support-daiichi-sankyo-submission-for-quizartinib-in-japan/>